Brief: MiMedx Group Engages Nordic Bioscience Clinical Development A/S To Propel Registrational Trials Of Placental Biologic Injectable For Knee Osteoarthritis
15/06/2022 13:33
June 15 (Reuters) - MiMedx Group Inc MDXG.O :
* MIMEDX ENGAGES NORDIC BIOSCIENCE CLINICAL DEVELOPMENT A/S
TO
PROPEL REGISTRATIONAL TRIALS OF PLACENTAL BIOLOGIC INJECTABLE
FOR KNEE OSTEOARTHRITIS
Source text for Eikon: ID:nGNXbsxDWm
Further company coverage: MDXG.O
((reuters.briefs@thomsonreuters.com;))
Recent news on MiMedx
See all newsBrief: Mimedx Announces Favorable Federal Court Ruling In Axiofill® Regulatory Classification Matter
MiMedx Group Inc reports results for the quarter ended June 30 - Earnings Summary
Brief: Mimedx To Acquire Sanara Medtech
MiMedx Q2 sales fall less than expected; set to acquire Sanara MedTech
Brief: MiMedx Q2 Sales USD 64.362 Million Vs. IBES Estimate USD 63.5 Million